Dan Yuan
Affiliations: | University of Washington, Seattle, Seattle, WA |
Google:
"Dan Yuan"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Chour W, Choi J, Xie J, et al. (2023) Large libraries of single-chain trimer peptide-MHCs enable antigen-specific CD8+ T cell discovery and analysis. Communications Biology. 6: 528 |
| Duvvuri VR, Baumgartner A, Molani S, et al. (2022) Angiotensin-Converting Enzyme (ACE) Inhibitors May Moderate COVID-19 Hyperinflammatory Response: An Observational Study with Deep Immunophenotyping. Health Data Science. 2022 |
| Goldman JD, Wang K, Röltgen K, et al. (2022) Reinfection with SARS-CoV-2 and Waning Humoral Immunity: A Case Report. Vaccines. 11 |
| Thompson RC, Simons NW, Wilkins L, et al. (2022) Molecular states during acute COVID-19 reveal distinct etiologies of long-term sequelae. Nature Medicine |
| Yuan D, Zhang Y, Li Y, et al. (2022) CD4(+) T Cell Count Progress and Influencing Factors of Recovery in AIDS Patients with Virological Failure in Sichuan Province: A Retrospective Cohort Study. Infection and Drug Resistance. 15: 6985-6999 |
| Heath J, Chour W, Choi J, et al. (2022) Large libraries of single-chain trimer peptide-MHCs enable rapid antigen-specific CD8+ T cell discovery and analysis. Research Square |
| Su Y, Yuan D, Chen DG, et al. (2022) Multiple early factors anticipate post-acute COVID-19 sequelae. Cell |
| Krämer B, Knoll R, Bonaguro L, et al. (2021) Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19. Immunity |
| Lee JW, Su Y, Baloni P, et al. (2021) Integrated analysis of plasma and single immune cells uncovers metabolic changes in individuals with COVID-19. Nature Biotechnology |
| Su Y, Chen D, Yuan D, et al. (2020) Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19. Cell |